The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry […]

A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]

Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]

Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]

Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]

Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]

Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]

Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]

Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]

In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% […]

The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]

  Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]

Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]

A new study evaluates the availability, quality and reimbursement of these tests in the European Union It proposes short and long-term measures to move towards precision […]

The European Regulation on Orphan Medicines of the year 2000 has been the key in this research launch A quarter of the annual approvals of new […]

Medications and vaccines don’t come out of nowhere. They are not done in a rush and they are not due to commercial gimmicks. They are the […]

Source: https: www.diariofarma.com Cancer continues to be one of the main fronts of the fight for drug research. On the occasion of tomorrow’s World Cancer Day […]

An American study indicates that these cells can fight breast, colon and lung cancer Source: www.redaccionmedica.com A new study, led by researchers at UT Southwestern (UTSW) […]

Source: www.lne.es New drugs are responsible for 73% of the prolongation of life expectancy in developed countries and have managed to solve more and more diseases. […]

Source: www.lavozdegalicia.es The sector has registered an investment in research and development of 1,211 million euros in 2019, 5.2% more than the previous year In these […]

Source: www.noticias.juridicas.com Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]

New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]

So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: www.redaccionmedica.com As part of its […]

In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate […]

The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to […]

Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the […]

  Source: www.redaccionmedica.com María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new […]